# Baseline Oral Health Study: UnCoVer the Connections to General Health

Study · id `cardio:ct-nct04954313` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04954313](<https://clinicaltrials.gov/study/NCT04954313>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04954313

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 786 participants.

## Technical summary

Registry record NCT04954313. Randomized; double masking; primary purpose prevention. Start 2021-09-28 (actual); primary completion 2025-02-01 (actual). Results posted on 2026-02-12.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 786 participants (enrolled count; ClinicalTrials.gov record NCT04954313, source copy `cardio:ctgov-nct04954313-2026-02-12`, retrieved 2026-10-26)
- Started: 2021-09-28 (actual) (ClinicalTrials.gov record NCT04954313, source copy `cardio:ctgov-nct04954313-2026-02-12`, retrieved 2026-10-26)
- Primary completion: 2025-02-01 (actual) (ClinicalTrials.gov record NCT04954313, source copy `cardio:ctgov-nct04954313-2026-02-12`, retrieved 2026-10-26)
- Completion: 2025-02-01 (actual) (ClinicalTrials.gov record NCT04954313, source copy `cardio:ctgov-nct04954313-2026-02-12`, retrieved 2026-10-26)
- Results first posted: 2026-02-12 (ClinicalTrials.gov record NCT04954313, source copy `cardio:ctgov-nct04954313-2026-02-12`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04954313, source copy `cardio:ctgov-nct04954313-2026-02-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04954313-2026-02-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Baseline Oral Health Study: UnCoVer the Connections to General Health
- Condition: Cardiovascular Diseases
- Condition: Diabetes Type 2
- Intervention (Drug): Subgingival chlorhexidine irrigation
- Intervention (Other): Dental Supplies
- Intervention (Other): Periodonal Treatment
- Lead sponsor: University of North Carolina, Chapel Hill
- Lead sponsor class: OTHER
- Collaborator: Colgate Palmolive
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: University of North Carolina, Chapel Hill (`cardio:org-university-of-north-carolina-chapel-hill`)

## Provenance

Content hash: 6a64117d4bbe44cc7fc937a761062b9df1b7829075cd70ad67a02f85920b97fc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
